Ivermectin found fame – and in some corners of the media, infamy – during the COVID-19 pandemic for it's groundbreaking use by medical experts in the early treatment of COVID. Ivermectin is, once again, being hailed as a medical miracle for it's potential application in the fight against cancer.

According to The Gateway Pundit,

A new cancer treatment protocol involving repurposed drugs Ivermectin, Fenbendazole, and Mebendazole has recently passed peer review and is being heralded as a potential breakthrough in cancer therapy.

The science behind the application of Ivermectin along with Mebendazole in the potential treatment of cancer is compelling:

This strategy is based on the mitochondrial-stem cell connection (MSCC) theory, which posits that cancer originates from impaired mitochondrial function in stem cells, leading to the formation of highly tumorigenic cancer stem cells (CSCs).

These CSCs are believed to drive tumor recurrence and metastasis and exhibit resistance to conventional therapies.